JLB & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-8,924
Closed -$673K 70
2017
Q4
$673K Hold
8,924
0.15% 64
2017
Q3
$650K Hold
8,924
0.16% 63
2017
Q2
$661K Buy
+8,924
New +$663K 0.17% 66
2016
Q4
$680K Sell
10,402
-4,991
-32% -$342K 0.18% 67
2016
Q3
$1.14M Sell
15,393
-1,215
-7% -$89.8K 0.31% 57
2016
Q2
$1.22M Buy
16,608
+7,522
+83% +$536K 0.34% 56
2016
Q1
$664K Sell
9,086
-7,772
-46% -$517K 0.17% 66
2015
Q4
$1.12M Sell
16,858
-350
-2% -$23.3K 0.35% 56
2015
Q3
$1.09M Hold
17,208
0.35% 57
2015
Q2
$1.13M Buy
17,208
+160
+0.9% +$10.9K 0.35% 58
2015
Q1
$1.18M Hold
17,048
0.37% 57
2014
Q4
$1.18M Hold
17,048
0.39% 55
2014
Q3
$1.11M Sell
17,048
-374
-2% -$24.7K 0.4% 56
2014
Q2
$1.19M Sell
17,422
-50
-0.3% -$3.35K 0.43% 54
2014
Q1
$1.13M Buy
17,472
+1,300
+8% +$81.9K 0.42% 55
2013
Q4
$1.05M Sell
16,172
-734
-4% -$47K 0.4% 54
2013
Q3
$1M Sell
16,906
-60
-0.4% -$3.56K 0.42% 53
2013
Q2
$971K Buy
+16,966
New +$1.01M 0.44% 54

Other funds holding CL

JLB & Associates's CL Position: Q1 2018 in Review

JLB & Associates sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 8,924 shares — an estimated $673K sold.

JLB & Associates first reported a position in CL in Q2 2013 and held it in 18 quarters. The position peaked at $1.22M in Q2 2016. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

  • JLB & Associates reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
  • JLB & Associates sold 8,924 Colgate-Palmolive shares in Q1 2018, an estimated $673K.
  • JLB & Associates first reported a position in Colgate-Palmolive in Q2 2013 and held it in 18 quarters.
  • JLB & Associates's Colgate-Palmolive position peaked at $1.22M in Q2 2016.
  • 1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on JLB & Associates's 13F filing for Q1 2018, filed 23 Apr 2018.